Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2011, Article ID 263725, 4 pages
http://dx.doi.org/10.1155/2011/263725
Case Report

Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation

1Department of Hematology, Hacettepe University Medical School, 06100 Ankara, Turkey
2Department of Genetics, Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey

Received 2 August 2011; Accepted 18 September 2011

Academic Editors: D. J. Allsup, S. Aref, E. Arellano-Rodrigo, and M.-C. Kyrtsonis

Copyright © 2011 B. Uz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

B. Uz, O. Bektas, E. Eliacik, et al., “Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation,” Case Reports in Hematology, vol. 2011, Article ID 263725, 4 pages, 2011. https://doi.org/10.1155/2011/263725.